269 Impact of levofloxacin prophylaxis utilization among neutropenic patients with haematologic malignancies

Saturday, April 25, 2009
Sophie Perriat, resident , CHU Lapeyronie, Montpellier, France
Emilie Talagrand, resident , CHU Lapeyronie, Montpellier, France
Jean Côme Meniane, hematologist , CHU Lapeyronie, Montpellier, France
Patrice Ceballos, hematologist , CHU Lapeyronie, Montpellier, France
Nathalie Fegueux, hematologist , CHU Lapeyronie, Montpellier, France